{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:07:00Z","timestamp":1792037220920,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dutch Ministry of Economic affairs"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04522-z","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T13:00:51Z","timestamp":1753534851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mesenchymal stromal cell-derived membrane particles suppress kidney fibrosis"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2429-714X","authenticated-orcid":false,"given":"Shengbing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Korevaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry P. P.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla C.","family":"Baan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies E. J.","family":"Reinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Hoogduijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"1","key":"4522_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","volume":"35","author":"N Yamashita","year":"2024","unstructured":"Yamashita N, Kramann R. Mechanisms of kidney fibrosis and routes towards therapy. Trends Endocrinol Metab. 2024;35(1):31\u201348.","journal-title":"Trends Endocrinol Metab"},{"key":"4522_CR2","doi-asserted-by":"publisher","first-page":"103942","DOI":"10.1016\/j.ebiom.2022.103942","volume":"77","author":"B Wang","year":"2022","unstructured":"Wang B, Li ZL, Zhang YL, Wen Y, Gao YM, Liu BC. Hypoxia and chronic kidney disease. EBioMedicine. 2022;77:103942.","journal-title":"EBioMedicine"},{"issue":"2","key":"4522_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199\u2013210.","journal-title":"J Pathol"},{"issue":"1","key":"4522_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8(1):129.","journal-title":"Signal Transduct Target Ther"},{"key":"4522_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-0716-1382-5_22","volume":"2299","author":"R Kramann","year":"2021","unstructured":"Kramann R, Menzel S. Mouse models of kidney fibrosis. Methods Mol Biol. 2021;2299:323\u201338.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"4522_CR6","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.34067\/KID.0000000000000227","volume":"4","author":"J Liang","year":"2023","unstructured":"Liang J, Liu Y. Animal models of kidney disease: challenges and perspectives. Kidney360. 2023;4(10):1479\u201393.","journal-title":"Kidney360."},{"issue":"7574","key":"4522_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","volume":"526","author":"M Takasato","year":"2015","unstructured":"Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015;526(7574):564\u20138.","journal-title":"Nature"},{"issue":"1","key":"4522_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.kint.2020.08.008","volume":"99","author":"AS Shankar","year":"2021","unstructured":"Shankar AS, Du Z, Mora HT, van den Bosch TPP, Korevaar SS, Van den Berg-Garrelds IM, et al. Human kidney organoids produce functional renin. Kidney Int. 2021;99(1):134\u201347.","journal-title":"Kidney Int"},{"issue":"2","key":"4522_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.kint.2024.10.028","volume":"107","author":"CW van den Berg","year":"2025","unstructured":"van den Berg CW, Dumas SJ, Little MH, Rabelink TJ. Challenges in maturation and integration of kidney organoids for stem cell-based renal replacement therapy. Kidney Int. 2025;107(2):262\u201370.","journal-title":"Kidney Int"},{"issue":"8","key":"4522_CR10","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3727\/096368911X623925","volume":"21","author":"C Donizetti-Oliveira","year":"2012","unstructured":"Donizetti-Oliveira C, Semedo P, Burgos-Silva M, Cenedeze MA, Malheiros DM, Reis MA, et al. Adipose tissue-derived stem cell treatment prevents renal disease progression. Cell Transplant. 2012;21(8):1727\u201341.","journal-title":"Cell Transplant"},{"issue":"1","key":"4522_CR11","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jss.2010.06.022","volume":"168","author":"H Asanuma","year":"2011","unstructured":"Asanuma H, Vanderbrink BA, Campbell MT, Hile KL, Zhang H, Meldrum DR, et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res. 2011;168(1):e51\u20139.","journal-title":"J Surg Res"},{"issue":"41","key":"4522_CR12","doi-asserted-by":"publisher","first-page":"70707","DOI":"10.18632\/oncotarget.19979","volume":"8","author":"F Zhu","year":"2017","unstructured":"Zhu F, Chong Lee Shin OLS, Pei G, Hu Z, Yang J, Zhu H, et al. Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation. Oncotarget. 2017;8(41):70707\u201326.","journal-title":"Oncotarget"},{"issue":"5","key":"4522_CR13","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.transproceed.2013.12.068","volume":"46","author":"S Iwai","year":"2014","unstructured":"Iwai S, Sakonju I, Okano S, Teratani T, Kasahara N, Yokote S, et al. Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat. Transplant Proc. 2014;46(5):1578\u201384.","journal-title":"Transplant Proc"},{"issue":"5","key":"4522_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/sctm.17-0186","volume":"7","author":"X Zou","year":"2018","unstructured":"Zou X, Jiang K, Puranik AS, Jordan KL, Tang H, Zhu X, et al. Targeting murine mesenchymal stem cells to kidney injury molecule-1 improves their therapeutic efficacy in chronic ischemic kidney injury. Stem Cells Transl Med. 2018;7(5):394\u2013403.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"4522_CR15","doi-asserted-by":"publisher","first-page":"10251","DOI":"10.1038\/s41598-024-60928-4","volume":"14","author":"S Kurawaki","year":"2024","unstructured":"Kurawaki S, Nakashima A, Ishiuchi N, Kanai R, Maeda S, Sasaki K, et al. Mesenchymal stem cells pretreated with interferon-gamma attenuate renal fibrosis by enhancing regulatory T cell induction. Sci Rep. 2024;14(1):10251.","journal-title":"Sci Rep"},{"key":"4522_CR16","doi-asserted-by":"publisher","first-page":"114191","DOI":"10.1016\/j.biopha.2022.114191","volume":"159","author":"F Amadeo","year":"2023","unstructured":"Amadeo F, Hanson V, Liptrott NJ, Wilm B, Murray P, Taylor A. Fate of intravenously administered umbilical cord mesenchymal stromal cells and interactions with the host\u2019s immune system. Biomed Pharmacother. 2023;159:114191.","journal-title":"Biomed Pharmacother"},{"key":"4522_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.","journal-title":"Front Immunol"},{"issue":"9","key":"4522_CR18","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.exphem.2008.03.019","volume":"36","author":"B Neuhuber","year":"2008","unstructured":"Neuhuber B, Swanger SA, Howard L, Mackay A, Fischer I. Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp Hematol. 2008;36(9):1176\u201385.","journal-title":"Exp Hematol"},{"issue":"1","key":"4522_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","volume":"14","author":"T Zhou","year":"2021","unstructured":"Zhou T, Yuan Z, Weng J, Pei D, Du X, He C, et al. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14(1):24.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"4522_CR20","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.110.239848","volume":"108","author":"JO Jeong","year":"2011","unstructured":"Jeong JO, Han JW, Kim JM, Cho HJ, Park C, Lee N, et al. Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res. 2011;108(11):1340\u20137.","journal-title":"Circ Res"},{"issue":"2","key":"4522_CR21","doi-asserted-by":"publisher","first-page":"e87853","DOI":"10.1371\/journal.pone.0087853","volume":"9","author":"HY Choi","year":"2014","unstructured":"Choi HY, Moon SJ, Ratliff BB, Ahn SH, Jung A, Lee M, et al. Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury. PLoS ONE. 2014;9(2):e87853.","journal-title":"PLoS ONE"},{"issue":"5","key":"4522_CR22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/ndt\/gfr015","volume":"26","author":"S Gatti","year":"2011","unstructured":"Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011;26(5):1474\u201383.","journal-title":"Nephrol Dial Transplant"},{"issue":"18","key":"4522_CR23","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1089\/scd.2012.0095","volume":"21","author":"HC Zhang","year":"2012","unstructured":"Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, et al. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev. 2012;21(18):3289\u201397.","journal-title":"Stem Cells Dev"},{"key":"4522_CR24","doi-asserted-by":"publisher","first-page":"30418","DOI":"10.1038\/srep30418","volume":"6","author":"S Kalimuthu","year":"2016","unstructured":"Kalimuthu S, Gangadaran P, Li XJ, Oh JM, Lee HW, Jeong SY, et al. In Vivo therapeutic potential of mesenchymal stem cell-derived extracellular vesicles with optical imaging reporter in tumor mice model. Sci Rep. 2016;6:30418.","journal-title":"Sci Rep"},{"key":"4522_CR25","doi-asserted-by":"crossref","unstructured":"Tejeda-Mora H, Leon LG, Demmers J, Baan CC, Reinders MEJ, Bleck B, et al. Proteomic Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicles and Reconstructed Membrane Particles. Int J Mol Sci. 22(23). 2021","DOI":"10.3390\/ijms222312935"},{"key":"4522_CR26","doi-asserted-by":"publisher","first-page":"114046","DOI":"10.1016\/j.biopha.2022.114046","volume":"157","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liang F, Zhang D, Qi S, Liu Y. Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: an emerging field of study to diagnostic and therapeutic purposes. Biomed Pharmacother. 2023;157:114046.","journal-title":"Biomed Pharmacother"},{"key":"4522_CR27","doi-asserted-by":"publisher","first-page":"877344","DOI":"10.3389\/fcell.2022.877344","volume":"10","author":"J Meldolesi","year":"2022","unstructured":"Meldolesi J. Unconventional protein secretion dependent on two extracellular vesicles: exosomes and ectosomes. Front Cell Dev Biol. 2022;10:877344.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"4522_CR28","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11095-024-03757-4","volume":"41","author":"Y Takakura","year":"2024","unstructured":"Takakura Y, Hanayama R, Akiyoshi K, Futaki S, Hida K, Ichiki T, et al. Quality and safety considerations for therapeutic products based on extracellular vesicles. Pharm Res. 2024;41(8):1573\u201394.","journal-title":"Pharm Res"},{"key":"4522_CR29","doi-asserted-by":"publisher","first-page":"31175","DOI":"10.1038\/srep31175","volume":"6","author":"Z Wei","year":"2016","unstructured":"Wei Z, Batagov AO, Carter DR, Krichevsky AM. Fetal bovine serum RNA interferes with the cell culture derived extracellular RNA. Sci Rep. 2016;6:31175.","journal-title":"Sci Rep"},{"issue":"8","key":"4522_CR30","doi-asserted-by":"publisher","first-page":"E968","DOI":"10.1073\/pnas.1521230113","volume":"113","author":"J Kowal","year":"2016","unstructured":"Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113(8):E968\u201377.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4522_CR31","doi-asserted-by":"publisher","first-page":"12100","DOI":"10.1038\/s41598-017-12121-z","volume":"7","author":"FDC Goncalves","year":"2017","unstructured":"Goncalves FDC, Luk F, Korevaar SS, Bouzid R, Paz AH, Lopez-Iglesias C, et al. Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes. Sci Rep. 2017;7(1):12100.","journal-title":"Sci Rep"},{"key":"4522_CR32","doi-asserted-by":"publisher","first-page":"651109","DOI":"10.3389\/fimmu.2021.651109","volume":"12","author":"GF da Costa","year":"2021","unstructured":"da Costa GF, Korevaar SS, Ortiz Virumbrales M, Baan CC, Reinders MEJ, Merino A, et al. Mesenchymal stromal cell derived membrane particles are internalized by macrophages and endothelial cells through receptor-mediated endocytosis and phagocytosis. Front Immunol. 2021;12:651109.","journal-title":"Front Immunol"},{"key":"4522_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jconrel.2022.08.060","volume":"350","author":"J Vos","year":"2022","unstructured":"Vos J, Tejeda-Mora H, Merino A, Wu L, Woud WW, Demmers JAA, et al. Bio-distribution and longevity of mesenchymal stromal cell derived membrane particles. J Control Release. 2022;350:642\u201351.","journal-title":"J Control Release"},{"issue":"3","key":"4522_CR34","doi-asserted-by":"publisher","first-page":"e0248415","DOI":"10.1371\/journal.pone.0248415","volume":"16","author":"A Merino","year":"2021","unstructured":"Merino A, Hoogduijn MJ, Molina-Molina M, Arias-Salgado EG, Korevaar SS, Baan CC, et al. Membrane particles from mesenchymal stromal cells reduce the expression of fibrotic markers on pulmonary cells. PLoS ONE. 2021;16(3):e0248415.","journal-title":"PLoS ONE"},{"issue":"1","key":"4522_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12917-020-02451-y","volume":"16","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. BMC Vet Res. 2020;16(1):242.","journal-title":"BMC Vet Res"},{"issue":"4","key":"4522_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/mt.2010.314","volume":"19","author":"E Warlich","year":"2011","unstructured":"Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, et al. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol Ther. 2011;19(4):782\u20139.","journal-title":"Mol Ther"},{"issue":"4","key":"4522_CR37","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.stemcr.2014.07.013","volume":"3","author":"CE de Esch","year":"2014","unstructured":"de Esch CE, Ghazvini M, Loos F, Schelling-Kazaryan N, Widagdo W, Munshi ST, et al. Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation. Stem Cell Reports. 2014;3(4):548\u201355.","journal-title":"Stem Cell Reports"},{"issue":"3","key":"4522_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40472-014-0017-6","volume":"1","author":"BR Slegtenhorst","year":"2014","unstructured":"Slegtenhorst BR, Dor FJ, Rodriguez H, Voskuil FJ, Tullius SG. Ischemia\/reperfusion Injury and its consequences on immunity and inflammation. Curr Transplant Rep. 2014;1(3):147\u201354.","journal-title":"Curr Transplant Rep"},{"issue":"9","key":"4522_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020;41(9):653\u201364.","journal-title":"Trends Pharmacol Sci"},{"key":"4522_CR40","doi-asserted-by":"crossref","unstructured":"Chatterjee E, Rodosthenous RS, Kujala V, Gokulnath P, Spanos M, Lehmann HI, et al. Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system. JCI Insight. 8(22). 2023","DOI":"10.1172\/jci.insight.165172"},{"issue":"4","key":"4522_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/ki.2012.105","volume":"82","author":"V Cantaluppi","year":"2012","unstructured":"Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012;82(4):412\u201327.","journal-title":"Kidney Int"},{"issue":"5","key":"4522_CR42","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3892\/ijmm.2014.1663","volume":"33","author":"C Grange","year":"2014","unstructured":"Grange C, Tapparo M, Bruno S, Chatterjee D, Quesenberry PJ, Tetta C, et al. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med. 2014;33(5):1055\u201363.","journal-title":"Int J Mol Med"},{"issue":"4","key":"4522_CR43","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1021\/acsnano.9b08207","volume":"14","author":"H Cao","year":"2020","unstructured":"Cao H, Cheng Y, Gao H, Zhuang J, Zhang W, Bian Q, et al. In vivo tracking of mesenchymal stem cell-derived extracellular vesicles improving mitochondrial function in renal ischemia-reperfusion Injury. ACS Nano. 2020;14(4):4014\u201326.","journal-title":"ACS Nano"},{"issue":"6","key":"4522_CR44","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1681\/ASN.2017121283","volume":"29","author":"DR Lemos","year":"2018","unstructured":"Lemos DR, McMurdo M, Karaca G, Wilflingseder J, Leaf IA, Gupta N, et al. Interleukin-1beta activates a MYC-dependent metabolic switch in kidney stromal cells necessary for progressive tubulointerstitial fibrosis. J Am Soc Nephrol. 2018;29(6):1690\u2013705.","journal-title":"J Am Soc Nephrol"},{"issue":"17","key":"4522_CR45","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1091\/mbc.e14-01-0044","volume":"25","author":"R Du","year":"2014","unstructured":"Du R, Xia L, Ning X, Liu L, Sun W, Huang C, et al. Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K\/Akt signal. Mol Biol Cell. 2014;25(17):2650\u20139.","journal-title":"Mol Biol Cell"},{"key":"4522_CR46","doi-asserted-by":"publisher","first-page":"927329","DOI":"10.3389\/fendo.2022.927329","volume":"13","author":"X Wei","year":"2022","unstructured":"Wei X, Hou Y, Long M, Jiang L, Du Y. Molecular mechanisms underlying the role of hypoxia-inducible factor-1 alpha in metabolic reprogramming in renal fibrosis. Front Endocrinol (Lausanne). 2022;13:927329.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4522_CR47","doi-asserted-by":"crossref","unstructured":"Miceli V, Bulati M, Gallo A, Iannolo G, Busa R, Conaldi PG, et al. Role of Mesenchymal Stem\/Stromal Cells in Modulating Ischemia\/Reperfusion Injury: Current State of the Art and Future Perspectives. Biomedicines. 11(3). 2023","DOI":"10.3390\/biomedicines11030689"},{"issue":"6","key":"4522_CR48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3727\/096368910X508762","volume":"19","author":"H Yagi","year":"2010","unstructured":"Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 2010;19(6):667\u201379.","journal-title":"Cell Transplant"},{"key":"4522_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jare.2022.05.012","volume":"45","author":"H Li","year":"2023","unstructured":"Li H, Dai H, Li J. Immunomodulatory properties of mesenchymal stromal\/stem cells: The link with metabolism. J Adv Res. 2023;45:15\u201329.","journal-title":"J Adv Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04522-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:58:49Z","timestamp":1757307529000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04522-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4522"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04522-z","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adipose tissue for MSC isolation and culture were collected from healthy donors as the part of project \u201cThe use of adipose tissue that becomes available as rest material after kidney transplantation from living donors\u201d approved by the medical ethics committee of the Erasmus University Medical Center (license number: MEC-2006\u2013190, approval date: 22nd August 2006). The animal studies were part of the project \u2018Regenerative and immunomodulatory therapies to improve the outcome of kidney transplantation\u2019, which received approval of the Dutch central committee animal experiments on 22nd September 2022 under license number AVD101002016635. iPSC were generated from skin of human donors as part of the project \u2018Creation of disease model systems to understand and correct genetic diseases through gene or other therapy using iPSC derived from somatic cells: iPSC protocol Rotterdam\u2019 approved by the Erasmus MC Medical Ethical Committee under approval number MEC-2017\u2013248, which was published 29th March 2018 and last updated 15th April 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to submission of the manuscript and agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}